In this study, to precisely investigate the molecular alteration in the very early stages of hepatocarcinogenesis, we used a cDNA microarray-based strategy to compare the gene expression profiles of chronic hepatitis C patients who were stratified according to their AFP levels. The gene discussed is AFP; the disease is chronic hepatitis C virus infection.